Welcome To dr holdright's practice

“Kind, Courteous, Gracious And Expert Care”
– Mrs GS, 2019

Dr Diana Holdright Cardiologist - Team Photo

Welcome to Dr Holdright's Practice


 “Kind, courteous, gracious and expert care” – Mrs GS, 2019

Dr Holdright’s private practice was established over 20 years ago and since that time she has earned a reputation as one of London’s finest cardiologists. Her broad experience scans the full spectrum of cardiological conditions and concerns, and she has access to the most state-of-the-art imaging techniques for fast and accurate diagnosis. Located within the Harley Street Clinic Diagnostic Centre in the heart of London’s medical district, she and her team are committed to providing a superlative service in a relaxed, welcoming and attentive environment.

"State of the art clinical service delivered efficiently and seamlessly by a leading Consultant Cardiologist with a flawless team"
"Absolutely amazing service. I have just told everyone in the office that if they need a cardiologist, this is the office to call"

"A very efficient, comprehensive and personalised service"

Latest News

Exercise after covid-19

For many people exercise is not just important for their physical health but also their mental wellbeing. People who have been hospitalised with Covid-19 or who have been unwell at home for a long period of time will naturally find it hard to return to their normal activity levels, and this is understandably a source

Read More »

Living with Long Covid

Over the last year we have heard a lot about the numbers of deaths from Covid-19, and also about the number of patients requiring ITU treatment to help them to survive the infection. What we have not heard so much about is what happens after hospital, when patients are discharged home and how some of

Read More »

ACEIs and ARBs in Covid-19

Membrane-bound angiotensin-converting enzyme 2 (ACE2) is the functional receptor for SARS-CoV-2, the virus which causes COVID-19. Drugs such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) upregulate ACE2, raising concerns about their safety in patients with COVID-19. The BRACE-CORONA trial is the first randomised trial to address the question of whether patients

Read More »
Scroll to Top